Evidence map›Paper›PMID 30936491›Full record

ReviewNature microbiology2019

Decoding type I and III interferon signalling during viral infection.

Emily V Mesev, Robert A LeDesma, Alexander Ploss

Open access · bronzeAbstract readReview
In one paragraph

Review in Nature microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 342 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
342citing papers in PubMed, 2 pooled it
23.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

342 citing papers in PubMed, 2 syntheses or guidelines pooled it, 529 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Manipulation of the cell cycle by HIV-1.Biochemical Society transactions · 2026
    Review
  6. Article
  7. Review
  8. PredictedInternational journal of molecular sciences · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

282 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Emily V Mesev *Lewis Thomas Laboratory, Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
Robert A LeDesma *Lewis Thomas Laboratory, Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
Alexander PlossLewis Thomas Laboratory, Department of Molecular Biology, Princeton University, Princeton, NJ, USA. aploss@princeton.edu.ORCID http://orcid.org/0000-0001-9322-7252
Princeton University · US

Funding

PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM007388 · NIGMS · PRINCETON UNIVERSITY · PI CRISTEA, ILEANA M. · 1985 to 2022
$27.4M
Genetic Viral and Host Adaptations to Breach Species Barriers of HCVR01AI107301 · NIAID · PRINCETON UNIVERSITY · PI Thomas Pietschmann, Alexander Ploss · 2013 to 2026
$6.0M
Modeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infectionR01AI138797 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PLOSS, ALEXANDER, SU, LISHAN · 2018 to 2022
$3.9M
NIAID NIH HHS R01 AI107301NIAID NIH HHS R01 AI138797NIGMS NIH HHS T32 GM007388
6 · The paper itself

Abstract

Interferon (IFN)-mediated antiviral responses are central to host defence against viral infection. Despite the existence of at least 20 IFNs, there are only three known cell surface receptors. IFN signalling and viral evasion mechanisms form an immensely complex network that differs across species. In this Review, we begin by highlighting some of the advances that have been made towards understanding the complexity of differential IFN signalling inputs and outputs that contribute to antiviral defences. Next, we explore some of the ways viruses can interfere with, or circumvent, these defences. Lastly, we address the largely under-reviewed impact of IFN signalling on host tropism, and we offer perspectives on the future of research into IFN signalling complexity and viral evasion across species.

Indexed as

AnimalsAntiviral AgentsGene Expression RegulationHost-Pathogen InteractionsHumansImmune EvasionImmunity, InnateInterferon LambdaInterferonsInterferon Type ISignal TransductionTropismVirus DiseasesVirusesAntiviral AgentsInterferon LambdaInterferonsInterferon Type I

Identifiers

PMID30936491
PMCPMC6554024
OpenAlexW2931678155

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.